Erin Michos, MD, MHS, opens a discussion surrounding the utilization of bempedoic acid for patients with intolerance to statin-based therapies.
ACC.23 Annual Scientific Session and Expo Together with the World Congress of Cardiology (WCC) 2023
Dr Michos offers strategies to successfully reduce LDL levels in patients with cardiovascular disease.
Hypercholesterolemia impact on cardiovascular outcomes is explored by a key opinion leader.
Dr Michos examines a controlled trial focusing on co-payment elimination and its effects on cardiovascular outcomes for low-income adults.
A medical expert discusses preauthorization requests and requirements for cardiovascular disease treatment, commenting on an abstract presented at the ACC 2023 Annual Scientific Session and Expo and World Congress of Cardiology.
In her closing thoughts, Dr Michos highlights social determinants of health impacting the treatment landscape for patients with cardiovascular disease.
Advertisement
Advertisement
Trending on AJMC
1
5 Consequences If ACA Premium Subsidies End in 2026
2
Culturally Competent Menopause Care: Lisa Taylor-Swanson, PhD
3
Stereotactic Body Radiation Therapy Equally Effective as Surgery in Stage I NSCLC
4
Age-Related Disparities in ADC Treatment Rates in Breast Cancer with Tabby Khan, MD
5
